Rubicon Genomics competitors

Rubicon Genomics Competitors include Healthcare Trust of America, HealthEquity, Oncimmune and NovoCure.
Add company...
Rubicon Genomics
Rubicon Genomics, Inc. engages in the development and commercialization of sample-specific nucleic acid library preparation products for use in research and clinical testing on next-generation sequencing (NGS), microarray, and q-PCR platforms.
Healthcare Trust of America
Healthcare Trust of America, Inc. (NYSE: HTA), a publicly traded real estate investment trust
HealthEquity
HealthEquity provides a range of solutions for managing healthcare accounts.
Oncimmune
Leader in early cancer detection
NovoCure
NovoCure engages in the development, manufacture and commercialization of tumor treating fields for the treatment of solid tumors.
Founding Date
Founding Date
2000
Founding Date
2006
Founding Date
2002
Founding Date
2006
Founding Date
2000
Type
Type
Private
Type
Public
Type
Public
Type
Private
Type
Public
Tags
Locations
Locations
Ann Arbor, US HQ
Locations
Scottsdale, US HQ
Locations
Draper, US HQ
Tucson, US
Overland Park, US
Locations
Nottingham, GB HQ
De Soto, US
Locations
Jersey, JE HQ
Munich, DE
Mannheim, DE
Haifa, IL
Haifa, IL
Chiyoda Ku, JP
Root, CH
see more
Employees
Employees
614% decrease
Employees
214
Employees
875
Employees
432% increase
Employees
460
Valuation ($)
Valuation ($)
N/A
Valuation ($)
5.2 b
Valuation ($)
5.1 b
Valuation ($)
N/A
Valuation ($)
4.1 b
Facebook likes
Facebook likes
110
Facebook likes
N/A
Facebook likes
1.3 k
Facebook likes
67
Facebook likes
N/A
Twitter followers
Twitter followers
183
Twitter followers
N/A
Twitter followers
903
Twitter followers
4.6 k
Twitter followers
992

Financial

Revenue (est.)
Revenue (est.)
N/A
Revenue (est.)
$460.9m (FY, 2016)
Revenue (est.)
$229.5m (FY, 2018)
Revenue (est.)
£80k (FY, 2017)
Revenue (est.)
N/A
Cost of goods
Cost of goods
N/A
Cost of goods
N/A
Cost of goods
$94.6m (FY, 2018)
Cost of goods
£248k (FY, 2017)
Cost of goods
N/A
Gross profit
Gross profit
N/A
Gross profit
N/A
Gross profit
$134.9m (FY, 2018)
Gross profit
(£168k) (FY, 2017)
Gross profit
N/A
Net income
Net income
N/A
Net income
$47.3m (FY, 2016)
Net income
$47.4m (FY, 2018)
Net income
(£4m) (FY, 2017)
Net income
N/A

Funding

Latest funding round
Latest funding round
$ 2m (over 3 years ago)
Latest funding round
N/A
Latest funding round
N/A
Latest funding round
$ 15m (almost 2 years ago)
Latest funding round
N/A
Total funding raised
Total funding raised
$ 5.5m
Total funding raised
N/A
Total funding raised
$ 12.5m
Total funding raised
$ 15m
Total funding raised
$ 116m
For sources of this data, please see the company profileDownload Excel

View company profiles

Healthcare Trust of America
HQ
Scottsdale, US
Employees
214

Healthcare Trust of America, Inc. (NYSE: HTA), a publicly traded real estate investment trust

View company
HealthEquity
HQ
Draper, US
Employees
875

HealthEquity provides a range of solutions for managing healthcare accounts.

View company
Oncimmune
HQ
Nottingham, GB
Employees
43↑ 2% increase

Leader in early cancer detection

View company
NovoCure
HQ
Jersey, JE
Employees
460

NovoCure engages in the development, manufacture and commercialization of tumor treating fields for the treatment of solid tumors.

View company